Renal dose dopamine: Myth or reality?;Dopamine a dose renale: Mythe ou realite?

Revue Medicale de la Suisse Romande

Volumn 119, Issue 3, 1999, Pages 203-208

  De Werra, Pierre ^a,b   Bracco, David ^a,c  

^a Service des Soins Intensifs   (Switzerland)

^b FMH Med Interne Néphrologie   (Switzerland)

^c NONE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; DOPAMINE; DOPAMINE RECEPTOR; CARDIOTONIC AGENT;

ACUTE KIDNEY FAILURE; BIOENERGY; CARDIOVASCULAR RISK; CLINICAL PROTOCOL; DOSE KIDNEY FUNCTION RELATION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HIGH RISK PATIENT; KIDNEY TUBULE NECROSIS; NATRIURESIS; NEPHROTOXICITY; SHORT SURVEY; TREATMENT OUTCOME; VASODILATATION; HEMODYNAMICS; HUMAN; KIDNEY; PATIENT SELECTION; PROGNOSIS; REVIEW; RISK FACTOR;

CARDIOTONIC AGENTS; DIURETICS; DOPAMINE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; KIDNEY FAILURE, ACUTE; PATIENT SELECTION; PROGNOSIS; RISK FACTORS;

EID: 0033086971     PISSN: 00353655     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. McDonald R.H., Goldberg L.I., McLay J.L.: Effects of dopamine man: Augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J. Clin. Invest., 43: 1116-1120, 1964.
2. Kleinknecht D., Pallot J.L.: Epidemiology and prognosis of acute renal insufficiency in 1997. Recent data. Nephrologie, 19: 49-55, 1998.
3. Menashe P.I., Ross S.A., Gottlieb J.E.: Acquired renal insufficiency in critically ill patients. Crit. Care Med., 1106-1109, 1998.
4. Frikha M., Montravers P., Vogel J., Enriquez I., Nimier M., Dureuil B., Desmont J.M.: Les scores de sévérité sous-estiment la sévérité de l'insuffisance rénale post-opératoire. Ann. Fr. Anesth. Réanim., 14: 478-483, 1995.
5. Chertow G.M.: On the design and analysis of multicenter trials in acute renal failure. Am. J. Kidney Dis., 30: S96-101, 1997.
6. Liano F., Junco E., Pascual J., Madero R., Verde E.: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. The Madrid Acute Renal Failure Study Group. Kidney Int. Supp., 66: S16-24, 1998.
7. Chan L., Shapiro J.I.: Contribution of nuclear magnetic resonnance to study of acute renal failure. Ren. Fail., 11: 79-89, 1989.
8. Lema G., Urzua J., Jalil R., Canessa R., Moran S., Sacco C., Medel J., Irarrazaval M., Zalaquett R., Fajardo C., Meneses G.: Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function (see comments). Anesth. Analg., 86: 3-8, 1998.
9. Chertow G.M., Levy E.M., Hammermeister K.E., Grover F., Daley J.: Independent association between acute renal failure and mortality following cardiac surgery. Am. J. Med., 104: 343-348, 1998.
10. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., O'Neil W.W.: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am. J. Med., 103: 368-375, 1997.
11. Myles P.S., Buckland M.R., Schenk N.J.: Effect of «renal dose» dopamine on renal function following cardiac surgery. Anesth. Intensive Care, 21: 56-61, 1993.
12. Baldwin L., Henderson A., Hickman P.: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann. Intern. Med., 120: 744-747, 1994.
13. Girbes A.R., Lieverse A.G., Smit A.J., van Veldhuisen D.J., Zwaveling J.H., Meijer S., Reitsma W.D.: Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery (see comments). Br. J. Anesth., 77: 353-357, 1996.
14. Memoli B., Libetta C., Conte G., Andreucci V.E.: Loop diuretics and renal vasodilators in acute renal failure. Nephrol. Dial. Transplant., 9 Suppl. 4: 168-171, 1994.
15. Chertow G.M., Sayegh M.H., Allgren R.L., Lazarus J.M.: Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group (see comments). Am. J. Med., 101:49-53, 1996.
16. Varriale P., Mossavi A.: The benefit of low-dose dopamine during vigorous diuresis for congestive heart failure associated with renal insufficiency: does it protect renal function? Clin. Cardiol., 20: 627-630, 1997.
17. Vargo D.L., Brater D.C., Rudy D.W., Swan S.K.: Dopamine does not enhance furosemide-induced natriuresis in patients with congestive heart failure. J. Am. Soc. Nephrol.; 7: 1032-1037, 1996.